Ikarian Capital’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.44M | Buy |
+1,035,528
| New | +$7.44M | 1.43% | 15 |
|
|
2023
Q4 | – | Sell |
-62,766
| Closed | -$612K | – | 90 |
|
|
2023
Q3 | $612K | Hold |
62,766
| – | – | 0.07% | 56 |
|
|
2023
Q2 | $743K | Hold |
62,766
| – | – | 0.12% | 52 |
|
|
2023
Q1 | $677K | Hold |
62,766
| – | – | 0.15% | 65 |
|
|
2022
Q4 | $726K | Sell |
62,766
-100,000
| -61% | -$1.16M | 0.18% | 40 |
|
|
2022
Q3 | $2.43M | Sell |
162,766
-87,234
| -35% | -$1.3M | 0.48% | 29 |
|
|
2022
Q2 | $2.26M | Buy |
+250,000
| New | +$2.26M | 0.41% | 27 |
|
|
2021
Q4 | – | Sell |
-30,727
| Closed | -$258K | – | 161 |
|
|
2021
Q3 | $258K | Sell |
30,727
-11,035
| -26% | -$92.7K | 0.02% | 136 |
|
|
2021
Q2 | $338K | Hold |
41,762
| – | – | 0.03% | 142 |
|
|
2021
Q1 | $367K | Hold |
41,762
| – | – | 0.01% | 152 |
|
|
2020
Q4 | $469K | Buy |
+41,762
| New | +$469K | 0.02% | 102 |
|